| Filed On | Filing |
|---|---|
| 12 Nov 2026 | 8-K: Other Events |
| 04 Nov 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
as Administrative Agent with respect to the EEA Agented Borrowers |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities
DUBLIN, IRELAND - (November 4, 2026) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2027 second quarter ended September 30, 2026. Total revenue for the second quarter of fiscal 2027 ... |
| 13 Oct 2026 |
8-K: Entry into a Material Definitive Agreement
On October 11, 2026, STERIS Corporation (“Purchaser”), a wholly owned subsidiary of STERIS plc (“STERIS” or the “Company”), entered into a Purchase and Sale Agreement (the “Purchase Agreement”) with Craig E. Kaforey, individually, as tru... |
| 06 Aug 2026 |
8-K: Submission of Matters to a Vote of Security Holders
At the 2026 Annual General Meeting of Shareholders (“Meeting”) of STERIS plc (the “Company”) held on July 31, 2026, shareholders voted on the matters specified below, with the final voting results as specified. According to the final rep... |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities
DUBLIN, IRELAND - (August 5, 2026) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2027 first quarter ended June 30, 2026. Total revenue for the first quarter of fiscal 2027 increased... |
| 11 May 2026 |
8-K: Results of Operations and Financial Condition
DUBLIN, IRELAND - (May 11, 2026) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 fourth quarter and full year ended March 31, 2026. Total revenue from continuing operations for t... |
| 07 May 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
DUBLIN, IRELAND, May 7, 2026 (GLOBE NEWSWIRE) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026, Pierre Boulud has been appointed to the Board of Directors. |
| 06 Apr 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 04 Feb 2026 |
8-K: Results of Operations and Financial Condition
Total revenue from continuing operations increased 9%; constant currency organic revenue grew 8% |
| 05 Nov 2025 |
8-K: Results of Operations and Financial Condition
DUBLIN, IRELAND - (November 5, 2025) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 second quarter ended September 30, 2025. Total revenue from continuing operations for the sec... |
| 06 Aug 2025 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
DUBLIN, IRELAND - (August 6, 2025) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 first quarter ended June 30, 2025. Total revenue from continuing operations for the first quart... |
| 03 Jul 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 14 May 2025 |
8-K: Results of Operations and Financial Condition
Full year fiscal 2025 as reported diluted EPS from continuing operations increased to $6.16; adjusted EPS per diluted share increased to $9.22 |
| 03 Mar 2025 |
8-K: Other Events
On March 3, 2025, Isomedix Operations, Inc. (“Isomedix”), a subsidiary of STERIS plc (“STERIS” or the “Company”), entered into binding confidential term sheets with plaintiffs’ counsel (the “Term Sheets”), as well as settlement agreement... |
| 05 Feb 2025 |
8-K: Results of Operations and Financial Condition
DUBLIN, IRELAND - (February 5, 2025) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 third quarter ended December 31, 2024. Total revenue from continuing operations for the third... |
| 06 Nov 2024 |
8-K: Results of Operations and Financial Condition
DUBLIN, IRELAND - (November 6, 2024) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 second quarter ended September 30, 2024. Total revenue from continuing operations for the sec... |
| 07 Oct 2024 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
Administrative Agent’s Office; Certain Addresses for Notices |
| 06 Aug 2024 |
8-K: Results of Operations and Financial Condition
DUBLIN, IRELAND - (August 6, 2024) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2025 first quarter ended June 30, 2024. Total revenue from continuing operations for the first quart... |
| 01 Aug 2024 |
8-K: Submission of Matters to a Vote of Security Holders
At the 2024 Annual General Meeting of Shareholders (“Meeting”) of STERIS plc (the “Company”) held on August 1, 2024, shareholders voted on the matters specified below, with the final voting results as specified. According to the final re... |
Loading...